World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
50
Citations
6589
World Ranking
5840
National Ranking
297

Roberto W. Invernizzi publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Roberto W. Invernizzi sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 102 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Roberto W. Invernizzi D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto W. Invernizzi sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 50 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Roberto W. Invernizzi is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, Invernizzi has focused on subfields including Genetics, Cognitive Neuroscience, Pharmacology, Physiology, and Psychiatry and Mental Health.

The scientist's work covers a range of topics, notably Genetics and Neurodevelopmental Disorders, Autism Spectrum Disorder Research, Pharmacology and Obesity Treatment, Family and Disability Support Research, Diabetes Treatment and Management, Diet and Metabolism Studies, and Neurological Disorders and Treatments.

Invernizzi has contributed to several publications across multiple journals and venues. Some notable recent papers include:

  • Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know (2021), published in Pharmacology & Therapeutics
  • Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin (2020), published in Neuropharmacology
  • Cerebrospinal fluid glutamate changes in functional movement disorders (2020), published in npj Parkinson's Disease
  • Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin (2021), published in Scientific Reports
  • Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report (2020), published in Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)

Frequent co-authors collaborating with Invernizzi include Claudia Villani, G. Sacchetti, Mirjana Carli, Reem Odi, and Tamar Gallily. These collaborations have resulted in multiple publications, indicating ongoing scientific partnerships.

The venues where Invernizzi's research appears most regularly are Scientific Reports, Zenodo (CERN European Organization for Nuclear Research), Pharmacology & Therapeutics, Neuropharmacology, and npj Parkinson's Disease.

Best Publications

  • Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

    Roberto Invernizzi;Stefano Belli;Rosario Samanin

  • Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.

    Mirjana Carli;Marta Baviera;Roberto W Invernizzi;Claudia Balducci

  • Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

    S. Garattini;T. Mennini;C. Bendotti;R. Invernizzi

  • Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity.

    Roberto Invernizzi;Mirjana Carli;Angelo Di Clemente;Rosario Samanin

  • Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression.

    Luigi Cervo;Alessandro Canetta;Eleonora Calcagno;Silvia Burbassi

  • Ropinirole and pramipexole promote structural plasticity in human iPSC- derived dopaminergic neurons via BDNF and mTOR signaling

    Ginetta Collo;Ginetta Collo;Laura Cavalleri;Federica Bono;Cristina Mora

  • Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms

    Gianluigi Forloni;Liana Terreni;Ilaria Bertani;Sergio Fogliarino

  • Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

    Roberto Invernizzi;Mario Bramante;Rosario Samanin

  • Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies

    Roberto W. Invernizzi;Silvio Garattini

  • Role of 5-HT1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex

    R. Invernizzi;M. Bramante;R. Samanin

  • 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.

    R.W. Invernizzi;L. Cervo;R. Samanin

  • Evidence that Extracellular Concentrations of Dopamine Are Regulated by Noradrenergic Neurons in the Frontal Cortex of Rats

    L. Pozzi;R. Invernizzi;L. Cervo;F. Vallebuona

  • D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat

    Roberto Invernizzi;Claudio Berettera;Silvio Garattini;Rosario Samanin

  • Stimulation of 5-hydroxytryptamine (5-HT2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex

    Laura Pozzi;Sabrina Acconcia;Ilaria Ceglia;Roberto W. Invernizzi

  • Effect of 5-HT1A Receptor Antagonists on Citalopram-induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus

    R Invernizzi;C Velasco;M Bramante;A Longo

  • Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes

    Marco Bacigaluppi;Gianluca Luigi Russo;Luca Peruzzotti-Jametti;Silvia Rossi

  • The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.

    Carli Mirjana;Marta Baviera;Roberto W Invernizzi;Claudia Balducci

  • α‐Synuclein and Parkinson's disease: Selective neurodegenerative effect of α‐synuclein fragment on dopaminergic neurons in vitro and in vivo

    Gianluigi Forloni;Ilaria Bertani;Anna Maria Calella;Florian Thaler

  • Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU2/3 receptor agonist LY379268

    Barbara Greco;Roberto W. Invernizzi;Mirjana Carli

  • Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram

    Roberto Invernizzi;Mario Bramante;Rosario Samanin

  • Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.

    G Sacchetti;M Bernini;A Bianchetti;S Parini

  • Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells.

    Emiliano Biasini;Luana Fioriti;Ilaria Ceglia;Roberto Invernizzi

Frequent Co-Authors

Rosario Samanin
Rosario Samanin Mario Negri Institute for Pharmacological Research
Silvio Garattini
Silvio Garattini Mario Negri Institute for Pharmacological Research
Gianluigi Forloni
Gianluigi Forloni Mario Negri Institute for Pharmacological Research
Claudia Balducci
Claudia Balducci Mario Negri Institute for Pharmacological Research
Giovanni Laviola
Giovanni Laviola Istituto Superiore di Sanità
Caterina Bendotti
Caterina Bendotti Mario Negri Institute for Pharmacological Research
Silvia Rossi
Silvia Rossi Chiesi (Italy)
Caterina Motta
Caterina Motta University of Rome Tor Vergata
Luigia Trabace
Luigia Trabace University of Foggia
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Neuroscience in the USA but are exploring flexible options, a variety of online degrees and certifications can help boost your career. While neuroscience typically requires lab work, many foundational courses and related subjects are now available online.

Pursuing one of the highest paying majors, such as biomedical engineering or computer science, can open doors to lucrative positions in health tech and neuroscience research. These pathways often intersect with neuroscience and can be started online before moving into advanced in-person study.

For those concerned about affordability, enrolling in fafsa-approved online certificate programs is a cost-effective way to advance your expertise. Many universities offer related certificates that can enhance your resume.

Not sure what certificates can help you transition? Explore what certificates can i get online—these qualifications can help you gain specialized knowledge in neuroscience-adjacent fields like data analysis or psychology.

If you want to build foundational knowledge with a lighter academic workload, take a look at the easiest online degree options. These programs can provide an introduction before you commit to more advanced neuroscience study.

Best Scientists Citing Roberto W. Invernizzi

Trending Scientists

Recently Published Articles